# FDA 483 - Biogen U.S. Corporation - August 26, 2022

Source: https://www.globalkeysolutions.net/records/483/biogen-us-corporation/667d7216-c2bd-4cea-a142-5c67b32a6b12

> FDA 483 for Biogen U.S. Corporation on August 26, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Biogen U.S. Corporation
- Inspection Date: 2022-08-26
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/biogen-us-corporation/4c9e7dca-e3ab-45d3-b244-cc16910d717d)
- [483 - 2022-12-09](https://www.globalkeysolutions.net/records/483/biogen-us-corporation/726781bf-1eb0-471e-85bb-fc1952ea7a7d)
- [483 - 2023-10-17](https://www.globalkeysolutions.net/records/483/biogen-us-corporation/3f37f544-3de5-4a34-8d51-b204e229b944)
- [483 - 2022-08-26](https://www.globalkeysolutions.net/records/483/biogen-us-corporation/486a3d3e-9172-42da-8392-59ebad2ec373)
- [483 - 2022-08-19](https://www.globalkeysolutions.net/records/483/biogen-us-corporation/4b8c485a-80e3-4311-999d-a8448d1caed5)

## Related Officers

- [Esther C. Broner](https://www.globalkeysolutions.net/people/esther-c-broner/5df7ca72-a21f-4586-a5e0-8a782045281c)
- [investigator](https://www.globalkeysolutions.net/people/wendy-guat-hoon-tan/c7353462-1299-46ae-a4b0-d832d870263d)

Company: https://www.globalkeysolutions.net/companies/biogen-us-corporation/515ce53c-77be-414c-bcf4-c66be60b098e

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd